Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction

Cardiovascular Research

Volumn 87, Issue 1, 2010, Pages 111-118

  Lord, Kevin C ^a,b   Shenouda, Sylvia K ^a   McIlwain, Elizabeth ^a   Charalampidis, Dimitrios ^d   Lucchesi, Pamela A ^a,c   Varner, Kurt J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF THE INCARNATE WORD   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d UNO College of Engineering   (United States)

Author keywords

Cardiac toxicity; Dilated myopathy; Drug abuse; Heart; Pressure volume relationship

Indexed keywords

CYTOCHROME C OXIDASE; DESMIN; HYDROETHIDINE; METHAMPHETAMINE; MYOSIN LIGHT CHAIN; PROHIBITIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE DISMUTASE; TEMPOL; 3-NITROTYROSINE; AMINE OXIDE; ANTIOXIDANT; MITOCHONDRIAL PROTEIN; SPIN LABELING; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEOMICS; RAT; ACTIN FILAMENT; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ECHOGRAPHY; HEART CATHETERIZATION; HEART CONTRACTION; HEART MUSCLE; HEART STROKE VOLUME; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; METABOLISM; PATHOPHYSIOLOGY; PREVENTION AND CONTROL; SPIN LABELING; SPRAGUE DAWLEY RAT; TIME;

ACTIN CYTOSKELETON; ANIMALS; ANTIOXIDANTS; CARDIAC CATHETERIZATION; CYCLIC N-OXIDES; DISEASE MODELS, ANIMAL; MALE; METHAMPHETAMINE; MITOCHONDRIAL PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SPIN LABELS; STROKE VOLUME; TIME FACTORS; TYROSINE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 77955162412     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq043     Document Type: Article

References (34)

1. Network DAW. National Estimates of drug-related emergency department visits. DAWN Series D-30 2006; DHHS Publication (SMA).
2. Westover AN, Nakonezny PA, Haley RW. Acute myocardial infarction in young adults who abuse amphetamines. Drug Alcohol Depend 2008;96:49-56.
3. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci 1999;44:359-368.
4. Wijetunga M, Seto T, Lindsay J, Schatz I. Crystal methamphetamine- associated cardi-omyopathy: tip of the iceberg? J Toxicol Clin Toxicol 2003;41:981-986.
5. He SY, Matoba R, Fujitani N, Sodesaki K, Onishi S. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol 1996;17:155-162.
6. Islam MN, Jesmine K, Kong Sn Molh A, Hasnan J. Histopathological studies of cardiac lesions after long term administration of methamphetamine in high dosage\Part II. Legal Med 2009;11:S147-S150.
7. Yu Q, Montes S, Larson DF, Watson RR. Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice. Life Sci 2002;71:953-965.
8. Varner KJ, Ogden BA, Delcarpio J, Meleg-Smith S. Cardiovascular responses elicited by the 'binge' administration of methamphetamine. J Pharmacol Exp Ther 2002;301: 152-159.
9. Jiang JP, Downing SE. Catecholamine cardiomyopathy: review and analysis of pathoge-netic mechanisms. Yale J Biol Med 1990;63:581-591.
10. Shenouda SK, Lord KC, McIlwain E, Lucchesi PA, Varner KJ. Ecstasy produces left ventricular dysfunction and oxidative stress in rats. Cardiovasc Res 2008;79:662-670.
11. Acikgoz O, Gonenc S, Kayatekin BM, Uysal N, Pekcetin C, Semin I et al. Methamphet-amine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum. Brain Res 1998;813:200-202.
12. Melega WP, Lacan G, Harvey DC, Way BM. Methamphetamine increases basal ganglia iron to levels observed in aging. Neuroreport 2007;18:1741-1745.
13. Davidson C, Gow AJ, Lee TH, Ellinwood EH. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Rev 2001;36:1-22.
14. Imam SZ, Newport GD, Itzhak Y, Cadet JL, Islam F, Slikker W Jr et al. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J Neurochem 2001;76:745-749.
15. Zhang X, Banerjee A, Banks WA, Ercal N. N-acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res 2009;1275:87-95.
16. Kadota T, Kadota K. Neurotoxic morphological changes induced in the medial pre-frontal cortex of rats behaviorally sensitized to methamphetamine. Arch Histol Cytol 2004;67:241-251.
17. Hisaki R, Fujita H, Saito F, Kushiro T. Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats. Am J Hypertens 2005;18:707-713.
18. Linares E, Giorgio S, Augusto O. Inhibition of in vivo leishmanicidal mechanisms by tempol: nitric oxide down-regulation and oxidant scavenging. Free Radic Biol Med 2008;44:1668-1676.
19. Xiang L, Dearman J, Abram SR, Carter C, Hester RL. Insulin resistance and impaired functional vasodilation in obese Zucker rats. Am J Physiol Heart Circ Physiol 2008;294: H1658-H1666.
20. Hong R, Matsuyama E, Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. J Am Med Assoc 1991;265:1152-1154.
21. Yeo KK, Wijetunga M, Ito H, Efird JT, Tay K, Seto TB et al. The association of meth-amphetamine use and cardiomyopathy in young patients. Am J Med 2007;120: 165-171.
22. Paulus WJ, Brutsaert DL. Relaxation abnormalities in cardiac hypertrophy. Eur Heart J 1982;3 (Suppl. A):133-137.
23. Brutsaert DL. Role of endocardium in cardiac overloading and failure. Eur Heart J 1990;11 (Suppl. G):8-16.
24. Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 2000;86:846-853.
25. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.
26. Madeira H. Diastolic heart failure: fact or myth? Rev Port Cardiol 2006;25: 883-886.
27. Melenovsky V, Borlaug BA, Rosen B, Hay I, Ferruci L, Morell CH et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol 2007;49:198-207.
28. Choksi KB, Boylston WH, Rabek JP, Widger WR, Papaconstantinou J. Oxidatively damaged proteins of heart mitochondrial electron transport complexes. Biochim Biophys Acta 2004;1688:95-101.
29. Han Z, Chen YR, Jones CI 3rd, Meenakshisundaram G, Zweier JL, Alevriadou BR. Shear-induced reactive nitrogen species inhibit mitochondrial respiratory complex activities in cultured vascular endothelial cells. Am J Physiol Cell Physiol 2007;292: C1103-C1112.
30. Berman SB, Hastings TG. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem 1999;73:1127-1137.
31. Da Cruz S, Parone PA, Gonzalo P, Bienvenut WV, Tondera D, Jourdain A et al. SLP-2 interacts with prohibitins in the mitochondrial inner membrane and contributes to their stability. Biochim Biophys Acta 2008;1783:904-911.
32. Osadchii OE, Norton GR, McKechnie R, Deftereos D, Woodiwiss AJ. Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation. Am J Physiol Heart Circ Physiol 2007;292: H1898-H1905.
33. Fornstedt B. Role of catechol autooxidation in the degeneration of dopamine neurons. Acta Neurol Scand Suppl 1990;129:12-14.
34. Alagarsamy S, Phillips M, Pappas T, Johnson KM. Dopamine neurotoxicity in cortical neurons. Drug Alcohol Depend 1997;48:105-111.